Auroempa L 25/5mg Tab

AUROEMPA L 25/5MG TAB is a combination medication primarily used for the management of Type 2 Diabetes Mellitus in adults. It is manufactured by Aurobindo Pharma Ltd..

Name

• Brand Name: AUROEMPA L 25/5MG TAB

Composition

• Active Ingredients: Each tablet contains Empagliflozin 25 mg and Linagliptin 5 mg.
  • Empagliflozin works by increasing the removal of glucose (sugar) from the body through urine by blocking a protein called SGLT-2 in the kidneys.
  • Linagliptin works by increasing the levels of natural substances called incretins, which stimulate insulin release after meals and reduce sugar production by the liver.

Uses

AUROEMPA L 25/5MG TAB is prescribed for:

• Treatment of Type 2 Diabetes Mellitus in adults, especially when diet and exercise alone are insufficient to control blood sugar levels.
• Reducing the risk of cardiovascular events, such as heart attack and stroke, in adults with Type 2 Diabetes who also have cardiovascular disease.
• Treating chronic kidney disease in adults with reduced kidney function, helping to protect kidneys from losing function.
• Preventing serious complications of diabetes, including kidney damage, eyesight loss (retinopathy), nerve damage (neuropathy), diabetic foot ulcers, and delayed wound healing.

Dosage and Administration

• Typically taken once daily, with or without food.
• It is recommended to take the tablet at the same time each day for consistent results.
• Swallow the tablet whole; do not crush, chew, or break it.
• Do not stop taking the medication suddenly without consulting a doctor, as this can lead to increased blood sugar levels and potential complications.

Side Effects

Common side effects may include:

• Urinary tract infections
• Nasopharyngitis
• Upper respiratory tract infections
• Cough, rash, itching
• Frequent urination
• Dizziness or lightheadedness
• Low blood sugar levels (hypoglycemia), especially when used with other diabetes medications like insulin or sulfonylureas, or with alcohol.

Precautions

• Contraindications: Do not use if allergic to empagliflozin, linagliptin, or any other ingredients.
• Not recommended for individuals with Type 1 Diabetes or diabetic ketoacidosis.
• Use with caution in patients with kidney or liver problems; severe kidney or liver disease may contraindicate its use.
• Avoid alcohol consumption as it can heighten the risk of low blood sugar or dehydration.
• Inform your doctor if you are pregnant or breastfeeding, as there is limited information, and it is advised to avoid use during these periods.
• Hydration is important, especially during physical activity or hot weather.
• Monitor blood sugar levels regularly.
• May interact with other medications, including insulin, sulfonylureas (which can increase the risk of hypoglycemia), and diuretics (which may lead to dehydration and low blood pressure).
• Consult a doctor if experiencing symptoms like severe dizziness, fainting, or signs of low blood sugar.
• Be aware of potential symptoms of pancreatitis, gallstones, low blood pressure, heart failure, high cholesterol, yeast infections, or nerve problems.

Storage

• Store at room temperature, away from moisture, excessive heat, and direct light.
• Keep it out of reach of children and pets.
• Specific temperature recommendations include storing in cool places at 10ºC to 25ºC or below 30ºC.
• Do not use the medication past its expiration date.

AUROEMPA L 25/5MG TAB is a combination medication used to manage Type 2 Diabetes Mellitus. It contains Empagliflozin (25mg) and Linagliptin (5mg).

What is AUROEMPA L 25/5MG TAB used for?

AUROEMPA L 25/5MG TAB is prescribed for adults with Type 2 Diabetes Mellitus to improve blood sugar control, especially when diet and exercise alone are not sufficient. It is also used to lower the risk of cardiovascular death in patients with Type 2 Diabetes and established cardiovascular disease. Additionally, it may be used to treat chronic kidney disease in adults with reduced kidney function.

How does AUROEMPA L 25/5MG TAB work?

This medicine combines two active ingredients with different mechanisms. Empagliflozin, an SGLT2 inhibitor, helps the kidneys remove excess glucose from the body through urine. Linagliptin, a DPP-4 inhibitor, works by increasing the levels of natural substances called incretins, which help the pancreas release more insulin and reduce the amount of sugar produced by the liver.

What is the usual dosage for AUROEMPA L 25/5MG TAB?

The usual dosage is one tablet (25mg Empagliflozin/5mg Linagliptin) once daily, typically taken in the morning. It can be taken with or without food. Your doctor will determine the appropriate dose for you, and it's important not to exceed the prescribed amount.

What are the possible side effects of AUROEMPA L 25/5MG TAB?

Common side effects include urinary tract infections (UTIs), frequent urination, nasopharyngitis (common cold symptoms), upper respiratory tract infections, dizziness, and lightheadedness. More serious but less common side effects can include ketoacidosis, pancreatitis, severe allergic reactions (like swelling of the face, lips, or throat), kidney problems, and a rare bacterial infection called Fournier's gangrene.

Is AUROEMPA L 25/5MG TAB safe during pregnancy or breastfeeding?

You should inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding before taking AUROEMPA L 25/5MG TAB. Generally, these types of medications are used with caution or not recommended during pregnancy and breastfeeding, and the decision should be made in consultation with your healthcare provider, weighing the potential benefits against risks.

Can AUROEMPA L 25/5MG TAB be taken with other medications?

AUROEMPA L 25/5MG TAB can often be taken with other diabetes medications like metformin. However, caution is advised when taking it with diuretics ("water pills") as it may increase the risk of dehydration. If taken with insulin or other insulin-releasing medications, there's an increased risk of low blood sugar (hypoglycemia). Always inform your doctor about all other medications, supplements, and herbal products you are taking.

What precautions should be taken while using AUROEMPA L 25/5MG TAB?

This medication is not for Type 1 Diabetes. It should be avoided if you have severe kidney or liver disease, or if you consume excessive alcohol. Maintain good genital hygiene to prevent yeast or urinary tract infections. Stay well-hydrated, especially during exercise or in hot weather, and rise slowly from a sitting or lying position to prevent dizziness. Regular monitoring of blood sugar levels and adherence to a healthy diet and exercise plan are crucial.

What happens if a dose of AUROEMPA L 25/5MG TAB is missed?

If you miss a dose, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.

How should AUROEMPA L 25/5MG TAB be stored?

Store the medicine in its original closed container at room temperature, away from excessive heat, moisture, and direct light, and out of reach of children.